Russia Secures Sputnik Italy Output in European Vaccine Push
This content was published on March 9, 2021 - 18:51
March 9, 2021 - 18:51
(Bloomberg) Russia is pushing ahead with plans to manufacture its Covid-19 vaccine in Europe, securing a deal to produce the Sputnik V shot in Italy and discussing production in Germany and France.
Adienne Pharma & Biotech SA signed an agreement to make the vaccine at its production site in the Milan region, founder and President Antonio Francesco Di Naro said in an interview.
The Lugano, Switzerland-based company’s deal with the Russian Direct Investment Fund is the first European production agreement for the vaccine. While Russia was first to approve a shot for the general public and promoted it as a way to help end the pandemic globally, it has been slower than some rivals to scale up output.
Russia s Sputnik V Vaccine to Be Produced in Italy amid Approval Row with EMA - Novinite com novinite.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from novinite.com Daily Mail and Mail on Sunday newspapers.
(Bloomberg) Russia is pushing ahead with plans to manufacture its Covid-19 vaccine in Europe, securing a deal to produce the Sputnik V shot in Italy and discussing production in Germany and France.Adienne Pharma & Biotech SA signed an agreement to make the vaccine at its production site in the Milan region, founder and President Antonio Francesco Di Naro said in an interview.The Lugano, Switzerland-based company’s deal with the Russian Direct Investment Fund is the first European production agreement for the vaccine. While Russia was first to approve a shot for the general public and promoted it as a way to help end the pandemic globally, it has been slower than some rivals to scale up output.Sputnik is more complicated to manufacture than some other vaccines because it’s based on two different adenoviruses for its two doses. Developers taking a similar approach, such as the University of Oxford and AstraZeneca Plc, have used only one virus.The vaccine is under rev